Vanda Pharmaceuticals Provides Update on Tradipitant Development Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/26/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY
6. UNP
7. GOOGL
8. RNG
9. TMUS
10. SPY

Go back to Vanda Pharmaceuticals Provides Update on Tradipitant Development Program
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Delayed: 5.18 -0.18 (3.36%)
Previous Close $5.36    52 Week High $18.00 
Open $5.38    52 Week Low $6.91 
Day High $5.39    P/E N/A 
Day Low $5.12    EPS $-0.67 
Volume 769,008